CUE BIOPHARMA INC's ticker is CUE and the CUSIP is 22978P106. A total of 101 filers reported holding CUE BIOPHARMA INC in Q2 2020. The put-call ratio across all filers is 1.33 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $278 | -94.4% | 121 | -89.9% | 0.00% | – |
| Q1 2022 | $5,000 | -61.5% | 1,203 | 0.0% | 0.00% | – |
| Q4 2021 | $13,000 | -23.5% | 1,203 | 0.0% | 0.00% | – |
| Q3 2021 | $17,000 | -97.7% | 1,203 | -98.1% | 0.00% | -100.0% |
| Q2 2021 | $728,000 | +118.6% | 62,563 | +128.1% | 0.00% | 0.0% |
| Q1 2021 | $333,000 | -47.6% | 27,430 | -46.1% | 0.00% | 0.0% |
| Q4 2020 | $636,000 | +27.7% | 50,897 | +53.5% | 0.00% | 0.0% |
| Q3 2020 | $498,000 | -38.4% | 33,150 | 0.0% | 0.00% | -50.0% |
| Q2 2020 | $809,000 | +15.4% | 33,150 | -33.2% | 0.00% | 0.0% |
| Q1 2020 | $701,000 | -15.3% | 49,653 | -4.9% | 0.00% | 0.0% |
| Q4 2019 | $828,000 | +1135.8% | 52,233 | +557.7% | 0.00% | – |
| Q3 2019 | $67,000 | – | 7,942 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 1,510,282 | $7,370,000 | 4.76% |
| SANDERS MORRIS HARRIS LLC | 873,021 | $4,261,000 | 0.83% |
| P.A.W. CAPITAL CORP | 150,000 | $732,000 | 0.76% |
| Nantahala Capital Management | 2,244,359 | $10,952,000 | 0.48% |
| Bleichroeder LP | 552,000 | $2,694,000 | 0.48% |
| APOGEM CAPITAL LLC | 111,259 | $543,000 | 0.37% |
| Slate Path Capital LP | 1,483,619 | $7,240,000 | 0.37% |
| Robertson Stephens Wealth Management, LLC | 478,500 | $2,335,000 | 0.20% |
| CARLSON CAPITAL L P | 405,000 | $1,976,000 | 0.14% |
| Bridgefront Capital, LLC | 19,968 | $97,000 | 0.12% |